医薬品中間体の世界市場レポート 2024年

医薬品中間体の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には6.4%の年間複合成長率（CAGR）で430億1,000万米ドルに成長すると予想されます。予測期間で予想される成長は、バイオ医薬品の革新、精密医療の開発、エコケミストリーの取り組み、カスタマイズ型中間体の生産、製薬アウトソーシングの一般的な動向などの要因に起因すると考えられます。予測期間中に予想される注目すべき動向には、連続フロー化学の採用、自動化とロボット工学の使用増加、ナノ技術の応用、生体触媒と酵素工学の進歩、医薬品中間体分野における戦略的サプライチェーン管理の導入が含まれます。

予想される慢性疾患の有病率の増加により、近い将来、医薬品中間体市場の成長が促進されると予想されます。 3か月以上続き、時間の経過とともに悪化する可能性がある慢性疾患は、高齢化、ライフスタイルの変化、急速な都市化、不十分な予防策などの要因により増加傾向にあります。 2022年3月、国立衛生研究所は、人口の13.4%が慢性腎障害に罹患すると予想され、推定490万2,000人から708万3,000人が末期腎疾患（ESKD）に対する腎代替療法を必要としていると報告しました。 医薬品中間体は、慢性疾患の管理に使用される医薬品の開発において重要な役割を果たし、慢性疾患の蔓延を緩和し、結果として医薬品中間体市場の成長を促進します。

医薬品生産の予想される増加は、医薬品中間体市場の拡大を推進することになるでしょう。医薬品の生産には、医薬品物質、医薬品、または薬剤の製造プロセスが含まれますが、医薬品がより複雑で標的を絞ったものになるにつれて、その合成には複数のステップが必要になります。 医薬品中間体は、製造プロセスの中間ステップで生成される化合物です。欧州製薬産業協会連盟（EFPIA）は2022年6月、欧州の医薬品総生産額が2021年に3,510億米ドル（3,000億ユーロ）に達し、2020年の3,352億米ドル（2,866億9,700万ユーロ）から5％増加したと報告しました。医薬品に対する需要の高まりが、医薬品中間体市場を推進する主要原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の医薬品中間体市場の促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の医薬品中間体市場規模実績と成長、2018～2023年
• 世界の医薬品中間体市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の医薬品中間体市場、製品別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 化学品中間体
• 原薬品中間体
• その他
• 世界の医薬品中間体市場、カテゴリー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• ブランド医薬品中間体
• ジェネリック医薬品中間体
• 世界の医薬品中間体市場、用途別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 鎮痛剤
• 抗感染症薬
• 心臓血管薬
• 経口糖尿病治療薬
• 抗菌薬
• その他
• 世界の医薬品中間体市場、エンドユーザー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• バイオテクノロジー企業と製薬企業
• 研究機関
• その他

第7章 地域と国の分析

• 世界の医薬品中間体市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界の医薬品中間体市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 医薬品中間体市場の競合情勢
• 医薬品中間体市場の企業プロファイル
  • BASF SE
  • Sanofi SA
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • Dishman Carbogen Amcis Ltd

第31章 その他の大手と革新的な企業

• Evonik Industries AG
• Arkema Inc.
• Lonza Group AG
• Wuxi AppTec co. Ltd
• Aurobindo Pharma Limited.
• Lianhe Chemical Technology Co. Ltd.
• Cambrex Corporation
• Vertellus Holdings LLC.
• Hovione LLC
• Hikal Ltd.
• Codexis Inc.
• Aceto Corporation
• Interchem Corporation
• Midas Pharma GmbH
• Arbiom

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

Pharmaceutical intermediates are chemical compounds or substances used in the synthesis and production of active pharmaceutical ingredients (APIs) or drug substances. These intermediates play a crucial role in the development and production of a wide range of drugs and therapeutic products, and they are utilized by pharmaceutical companies and research institutions.

The main types of pharmaceutical intermediates products include chemical intermediates, bulk drug intermediates, and other products. Chemical intermediates are compounds or substances produced during the manufacturing process of chemicals and find applications in various industries, including pharmaceuticals, agrochemicals, polymers, and specialty chemicals. Categories of pharmaceutical intermediates include branded drug intermediates and generic drug intermediates. The applications of pharmaceutical intermediates cover various drugs such as analgesics, anti-infective drugs, cardiovascular drugs, oral antidiabetic drugs, antimicrobial drugs, and others. The end-users of pharmaceutical intermediates include biotech and pharma companies, research institutions, and others.

The pharmaceutical intermediates market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical intermediates market statistics, including pharmaceutical intermediates industry global market size, regional shares, competitors with a pharmaceutical intermediates market share, detailed pharmaceutical intermediates market segments, market trends, and opportunities, and any further data you may need to thrive in the pharmaceutical intermediates industry. This pharmaceutical intermediate market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical intermediates market size has grown strongly in recent years. It will grow from $31.33 billion in 2023 to $33.59 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth observed in the historical period can be attributed to various factors, including advancements in chemical synthesis techniques, the evolution of drug development processes, market demand and expansion, increased investment in research and development, and adherence to regulatory compliance standards.

The pharmaceutical intermediates market size is expected to see strong growth in the next few years. It will grow to $43.01 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The anticipated growth in the forecast period can be attributed to factors such as innovation in biopharmaceuticals, the development of precision medicine, initiatives in green chemistry, the production of customized intermediates, and prevailing trends in pharmaceutical outsourcing. Noteworthy trends expected in the forecast period encompass the adoption of continuous flow chemistry, increased use of automation and robotics, the application of nanotechnology, advancements in biocatalysis and enzyme engineering, and the implementation of strategic supply chain management in the pharmaceutical intermediates sector.

The anticipated increase in the prevalence of chronic diseases is poised to drive the growth of the pharmaceutical intermediates market in the foreseeable future. Chronic diseases, characterized by lasting three months or longer and having the potential to worsen over time, are on the rise due to factors such as an aging population, lifestyle changes, rapid urbanization, and insufficient preventive measures. In March 2022, the National Institute of Health reported that chronic kidney disorders are expected to affect 13.4% of the population, with an estimated 4.902 to 7.083 million individuals requiring renal replacement therapy for end-stage kidney disease (ESKD). Pharmaceutical intermediates play a vital role in developing medications used to manage chronic diseases, mitigating the escalating prevalence of such conditions and consequently driving the pharmaceutical intermediates market's growth.

The expected increase in pharmaceutical drug production is set to propel the pharmaceutical intermediates market's expansion. Drug production involves the manufacturing process of pharmaceutical substances, medications, or drugs, and as pharmaceutical drugs become more complex and targeted, their synthesis requires multiple steps. Pharmaceutical intermediates are chemical compounds produced during these intermediate steps in the manufacturing process. The European Federation of Pharmaceutical Industries and Associations (EFPIA) reported in June 2022 that the total pharmaceutical production in Europe reached $351 billion (€300,000 million) in 2021, marking a 5% increase from $335.2 billion (€286,697 million) in 2020. The growing demand for pharmaceutical drugs is a key driver propelling the pharmaceutical intermediates market.

Leading companies in the pharmaceutical intermediates market are introducing new product lines, such as API Intermediates, to enhance their market position and profitability. API intermediates, which are chemical compounds used in the synthesis of active pharmaceutical ingredients (APIs), play a crucial role in producing medications for various therapeutic areas. In October 2023, Huateng Pharmaceutical Co. Ltd., a China-based pharmaceutical company, launched its Gastrointestinal API Intermediates product line. These intermediates serve as building blocks for pharmaceutical active ingredients used in medications treating gastrointestinal system disorders, including laxatives, 5-HT3 receptor antagonists, H2-receptor antagonists, and proton pump inhibitors.

Major players in the pharmaceutical intermediates market are focusing on developing intermediates specifically for small molecule drugs. Intermediates are transitional products formed during different stages of the chemical manufacturing process before reaching the final active pharmaceutical ingredient (API) or drug substance, playing a crucial role in the synthesis of small molecule drugs. Sumitomo Chemical Co., Ltd., a Japan-based chemical company, launched active pharmaceutical ingredients (APIs) and intermediates for small molecule drugs in March 2022. This initiative aims to meet the growing demand for small molecule medications by offering a broader range of premium APIs and intermediates.

In May 2021, Aceto Corporation, a US-based provider of specialty materials, acquired Finar Limited, an India-based manufacturer and supplier of high-purity solvents and chemicals. This acquisition aligns with Aceto's growth strategy, enhancing its manufacturing footprint, research and development (R&D) capabilities, and quality expertise in the pharmaceutical intermediates market. The collaboration with Finar Limited allows Aceto to expand its product offerings and strengthen its position in the industry.

Major companies operating in the pharmaceutical intermediates market report are BASF SE, Sanofi SA, Thermo Fisher Scientific Inc., Merck KGaA, Dishman Carbogen Amcis Ltd., Evonik Industries AG, Arkema Inc., Lonza Group AG, Wuxi AppTec co. Ltd., Aurobindo Pharma Limited, Lianhe Chemical Technology Co. Ltd., Cambrex Corporation, Vertellus Holdings LLC., Hovione LLC, Hikal Ltd., Codexis Inc., Aceto Corporation, Interchem Corporation, Midas Pharma GmbH, Arbiom, Dextra Laboratories Ltd., A. R. Life Sciences, Ingenza Ltd., Chiracon GmbH, Dyadic International Inc., Elam Pharma Pvt Ltd., Yin-sheng Bio-tech Co. Ltd., Green Vision Life Sciences, Sibylla Biotech s.r.l., Pfizer CentreOne

North America was the largest region in the pharmaceutical intermediates market in 2023. The regions covered in the pharmaceutical intermediates market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceutical intermediates market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical intermediates market consists of sales of intermediates for API synthesis, API precursors, fine chemicals, and specialty chemicals. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Intermediates Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical intermediates market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical intermediates ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical intermediates market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Chemical Intermediate; Bulk Drug Intermediate; Other Products
• 2) By Category: Branded Drug Intermediate; Generic Drug Intermediate
• 3) By Application: Analgesics; Anti-Infective Drugs; Cardiovascular Drugs; Oral Antidiabetic Drugs; Antimicrobial Drugs; Other Applications
• 4) By End-User: Biotech And Pharma Companies; Research Institutions; Other End-Users
• Companies Mentioned: BASF SE; Sanofi SA; Thermo Fisher Scientific Inc; Merck KGaA; Dishman Carbogen Amcis Ltd
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Intermediates Market Characteristics

3. Pharmaceutical Intermediates Market Trends And Strategies

4. Pharmaceutical Intermediates Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Pharmaceutical Intermediates Market Size and Growth

• 5.1. Global Pharmaceutical Intermediates Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Pharmaceutical Intermediates Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Pharmaceutical Intermediates Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pharmaceutical Intermediates Market Segmentation

• 6.1. Global Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Chemical Intermediate
• Bulk Drug Intermediate
• Other Products
• 6.2. Global Pharmaceutical Intermediates Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Branded Drug Intermediate
• Generic Drug Intermediate
• 6.3. Global Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Analgesics
• Anti-Infective Drugs
• Cardiovascular Drugs
• Oral Antidiabetic Drugs
• Antimicrobial Drugs
• Other Applications
• 6.4. Global Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Biotech And Pharma Companies
• Research Institutions
• Other End-Users

7. Pharmaceutical Intermediates Market Regional And Country Analysis

• 7.1. Global Pharmaceutical Intermediates Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Pharmaceutical Intermediates Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pharmaceutical Intermediates Market

• 8.1. Asia-Pacific Pharmaceutical Intermediates Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pharmaceutical Intermediates Market

• 9.1. China Pharmaceutical Intermediates Market Overview
• 9.2. China Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pharmaceutical Intermediates Market

• 10.1. India Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pharmaceutical Intermediates Market

• 11.1. Japan Pharmaceutical Intermediates Market Overview
• 11.2. Japan Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pharmaceutical Intermediates Market

• 12.1. Australia Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pharmaceutical Intermediates Market

• 13.1. Indonesia Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pharmaceutical Intermediates Market

• 14.1. South Korea Pharmaceutical Intermediates Market Overview
• 14.2. South Korea Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pharmaceutical Intermediates Market

• 15.1. Western Europe Pharmaceutical Intermediates Market Overview
• 15.2. Western Europe Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pharmaceutical Intermediates Market

• 16.1. UK Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pharmaceutical Intermediates Market

• 17.1. Germany Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pharmaceutical Intermediates Market

• 18.1. France Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pharmaceutical Intermediates Market

• 19.1. Italy Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pharmaceutical Intermediates Market

• 20.1. Spain Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pharmaceutical Intermediates Market

• 21.1. Eastern Europe Pharmaceutical Intermediates Market Overview
• 21.2. Eastern Europe Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pharmaceutical Intermediates Market

• 22.1. Russia Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pharmaceutical Intermediates Market

• 23.1. North America Pharmaceutical Intermediates Market Overview
• 23.2. North America Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pharmaceutical Intermediates Market

• 24.1. USA Pharmaceutical Intermediates Market Overview
• 24.2. USA Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pharmaceutical Intermediates Market

• 25.1. Canada Pharmaceutical Intermediates Market Overview
• 25.2. Canada Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pharmaceutical Intermediates Market

• 26.1. South America Pharmaceutical Intermediates Market Overview
• 26.2. South America Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pharmaceutical Intermediates Market

• 27.1. Brazil Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pharmaceutical Intermediates Market

• 28.1. Middle East Pharmaceutical Intermediates Market Overview
• 28.2. Middle East Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pharmaceutical Intermediates Market

• 29.1. Africa Pharmaceutical Intermediates Market Overview
• 29.2. Africa Pharmaceutical Intermediates Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Pharmaceutical Intermediates Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Pharmaceutical Intermediates Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pharmaceutical Intermediates Market Competitive Landscape And Company Profiles

• 30.1. Pharmaceutical Intermediates Market Competitive Landscape
• 30.2. Pharmaceutical Intermediates Market Company Profiles
  • 30.2.1. BASF SE
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Sanofi SA
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Thermo Fisher Scientific Inc
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Merck KGaA
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Dishman Carbogen Amcis Ltd
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Pharmaceutical Intermediates Market Other Major And Innovative Companies

• 31.1. Evonik Industries AG
• 31.2. Arkema Inc.
• 31.3. Lonza Group AG
• 31.4. Wuxi AppTec co. Ltd
• 31.5. Aurobindo Pharma Limited.
• 31.6. Lianhe Chemical Technology Co. Ltd.
• 31.7. Cambrex Corporation
• 31.8. Vertellus Holdings LLC.
• 31.9. Hovione LLC
• 31.10. Hikal Ltd.
• 31.11. Codexis Inc.
• 31.12. Aceto Corporation
• 31.13. Interchem Corporation
• 31.14. Midas Pharma GmbH
• 31.15. Arbiom

32. Global Pharmaceutical Intermediates Market Competitive Benchmarking

33. Global Pharmaceutical Intermediates Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pharmaceutical Intermediates Market

35. Pharmaceutical Intermediates Market Future Outlook and Potential Analysis

• 35.1 Pharmaceutical Intermediates Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Pharmaceutical Intermediates Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Pharmaceutical Intermediates Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer